Stockreport

Crinetics Pharmaceuticals Inc (CRNX) Reports Increased R&D Investment Amidst Net Loss ... [Yahoo! Finance]

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report
PDF General and Administrative Expenses : Rose to $58.1 million in 2023 from $42.4 million in 2022. Net Loss : Widened to $214.5 million in 2023 from $163.9 million in 20 [Read more]